Skip Navigation

Publication Detail

Title: Particulate hexavalent chromium alters microRNAs in human lung cells that target key carcinogenic pathways.

Authors: Speer, Rachel M; Meaza, Idoia; Toyoda, Jennifer H; Lu, Yuan; Xu, Qian; Walter, Ronald B; Kong, Maiying; Lu, Haiyan; Kouokam, J Calvin; Wise Sr, John Pierce

Published In Toxicol Appl Pharmacol, (2022 Mar 01)

Abstract: Hexavalent chromium [Cr(VI)] is a global environmental pollutant and human lung carcinogen. However, the mechanisms of Cr(VI) carcinogenesis are not well defined. Cr(VI)-altered gene expression has been reported in the literature and is implicated in numerous mechanisms of Cr(VI) carcinogenesis. MicroRNAs (miRNAs) play a key role in controlling gene expression and are associated with carcinogenic mechanisms. To date no studies have evaluated global changes in miRNA expression in human cells after Cr(VI) exposure. We used RNA sequencing to evaluate how a particulate Cr(VI) compound (zinc chromate), the most potent form of Cr(VI), alters global miRNA expression after acute (24 h) or prolonged (72 and 120 h) exposure to 0.1, 0.2 and 0.3 μg/cm2 zinc chromate in an immortalized, non-cancerous human lung cell line (WTHBF-6). Particulate Cr(VI) significantly affected expression of miRNAs at all time points and concentrations tested. We also found the number of significantly downregulated miRNAs increased in a time- and concentration-dependent manner and many miRNAs were upregulated after 24 h exposure at the intermediate concentration tested. Pathway analyses of the differentially expressed miRNAs predicted miRNAs target pathways of Cr(VI) carcinogenesis in a time- and concentration-dependent manner. These data are the first to evaluate global changes in miRNA expression in human lung cells after Cr(VI) exposure and indicate miRNAs may play a key role in pathways of Cr(VI) carcinogenesis.

PubMed ID: 35101437 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top